Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Redirected T Cell Cytotoxicity in Cancer Therapy.

Clynes RA, Desjarlais JR.

Annu Rev Med. 2018 Oct 31. doi: 10.1146/annurev-med-062617-035821. [Epub ahead of print]

PMID:
30379598
2.

Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation.

Do C, Lang CF, Lin J, Darbary H, Krupska I, Gaba A, Petukhova L, Vonsattel JP, Gallagher MP, Goland RS, Clynes RA, Dwork A, Kral JG, Monk C, Christiano AM, Tycko B.

Am J Hum Genet. 2016 May 5;98(5):934-955. doi: 10.1016/j.ajhg.2016.03.027.

3.

Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.

Flynn R, Allen JL, Luznik L, MacDonald KP, Paz K, Alexander KA, Vulic A, Du J, Panoskaltsis-Mortari A, Taylor PA, Poe JC, Serody JS, Murphy WJ, Hill GR, Maillard I, Koreth J, Cutler CS, Soiffer RJ, Antin JH, Ritz J, Chao NJ, Clynes RA, Sarantopoulos S, Blazar BR.

Blood. 2015 Jun 25;125(26):4085-94. doi: 10.1182/blood-2014-08-595470. Epub 2015 Apr 7.

4.

ILT3.Fc inhibits the production of exosomes containing inflammatory microRNA in supernatants of alloactivated T cells.

Xu Z, Ho S, Chang CC, Liu Z, Li M, Vasilescu ER, Clynes RA, Vlad G, Suciu-Foca N.

Hum Immunol. 2014 Aug;75(8):756-9. doi: 10.1016/j.humimm.2014.05.006. Epub 2014 May 24.

PMID:
24862932
5.

Detection of donor-specific-antibodies by solid phase assay and its relevance to complement-dependent-lymphocytotoxicity cross-matching in kidney transplantation.

Ho EK, Vasilescu ER, Vlad G, Clynes RA, Ratner LE, Suciu-Foca N.

Hum Immunol. 2014 Jun;75(6):520-3. doi: 10.1016/j.humimm.2014.03.002. Epub 2014 Mar 21.

PMID:
24662417
6.

Allospecific CD8 T suppressor cells induced by multiple MLC stimulation or priming in the presence of ILT3.Fc have similar gene expression profiles.

Chen L, Xu Z, Chang C, Ho S, Liu Z, Vlad G, Cortesini R, Clynes RA, Luo Y, Suciu-Foca N.

Hum Immunol. 2014 Feb;75(2):190-6. doi: 10.1016/j.humimm.2013.10.004. Epub 2013 Nov 9.

PMID:
24220571
7.

Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells.

Chang CC, Zhang QY, Liu Z, Clynes RA, Suciu-Foca N, Vlad G.

J Immunol. 2012 Apr 1;188(7):3042-52. doi: 10.4049/jimmunol.1102899. Epub 2012 Mar 2.

8.

Mouse models of IgG- and IgM-mediated hemolysis.

Schirmer DA, Song SC, Baliff JP, Harbers SO, Clynes RA, Krop-Watorek A, Halverson GR, Czerwinski M, Spitalnik SL.

Blood. 2007 Apr 1;109(7):3099-107.

9.

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo.

Trcka J, Moroi Y, Clynes RA, Goldberg SM, Bergtold A, Perales MA, Ma M, Ferrone CR, Carroll MC, Ravetch JV, Houghton AN.

Immunity. 2002 Jun;16(6):861-8.

10.

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.

Clynes RA, Towers TL, Presta LG, Ravetch JV.

Nat Med. 2000 Apr;6(4):443-6.

PMID:
10742152
11.

Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor.

Dyall R, Vasovic LV, Clynes RA, Nikolić-Zugić J.

Eur J Immunol. 1999 Jan;29(1):30-7.

12.

Divergent roles for Fc receptors and complement in vivo.

Ravetch JV, Clynes RA.

Annu Rev Immunol. 1998;16:421-32. Review.

PMID:
9597136
13.

Synergy between an antibody and CD8+ cells in eliminating an established tumor.

Vasović LV, Dyall R, Clynes RA, Ravetch JV, Nikolić-Zugic J.

Eur J Immunol. 1997 Feb;27(2):374-82.

PMID:
9045907
14.

Rearrangement and expression of T cell receptor and immunoglobulin loci in immortalized CD4-CD8- T cell lines.

Primi D, Clynes RA, Jouvin-Marche E, Marolleau JP, Barbier E, Cazenave PA, Marcu KB.

Eur J Immunol. 1988 Jul;18(7):1101-9.

PMID:
2969819

Supplemental Content

Loading ...
Support Center